DH - CIK 0001861795
Definitive Healthcare Corp. trades as DH. In its fiscal 2025 annual report the company posted revenue of $241.52M, down 4.2% from the prior year and net income of -$138.93M. This page tracks Definitive Healthcare Corp. through 361 SEC filings, with financial statements and metrics updated as new reports are filed.
Over the last 5 fiscal years Definitive Healthcare Corp.'s revenue grew from $118.32M to $241.52M, a compound annual growth rate of 15.3%. Net profit margin compressed from 0.0% to -57.5% over the same period - every figure below comes from the company's audited annual filings.
| Filing | Type | Filed |
|---|---|---|
| SCHEDULE 13G/A | - | 2026-05-14 |
| Quarterly report | 10-Q | 2026-05-07 |
| Major company event | 8-K | 2026-05-07 |
| Insider trade | 4 | 2026-05-05 |
| Insider trade | 4 | 2026-05-05 |
| Annual report to shareholders | ARS | 2026-04-23 |
| Proxy materials | DEFA14A | 2026-04-23 |
| Proxy statement | DEF 14A | 2026-04-23 |
The largest companies sharing Definitive Healthcare Corp.'s SEC industry classification (services-prepackaged software).
Definitive Healthcare Corp. reported revenue of $241.52M for fiscal year 2025, a decrease of 4.2% year over year.
In its latest fiscal year Definitive Healthcare Corp. reported a net loss of $138.93M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.